Navigation Links
Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
Date:11/15/2007

all and live webcast at 9:00 a.m. ET today to discuss the results from Trial CL-05 and the third quarter 2007 financial results. On the call, Advanced Life Sciences management will be joined by Donald E. Low, M.D., a recognized authority in microbiology and infectious diseases.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of Advanced Life Sciences' corporate website http://www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing 866-510-0704 (domestic) or 617-597-5362 (international). The passcode for the conference call is 57071751.

A telephone replay of the call will also be available for 48 hours. Callers may access the telephone replay by dialing (domestic) 888-286-8010 or 617-801-6888 (international), passcode 51192916.

About Community Acquired Pneumonia (CAP)

CAP is the sixth most common cause of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. CAP affects 5.6 million patients in the United States each year, with 10 million physician visits and 2 million hospitalizations occurring annually.

Macrolides and penicillins are currently the front-line treatments for respiratory tract infections such as CAP. As macrolide and penicillin resistance grows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action that can overcome this emerging resistance.

About Cethromycin

Cethromycin has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections, and, again in in vitro tests, it appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of act
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
4. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
6. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
9. Spherix Reports Second Quarter Earnings
10. Tapestry Reports Second Quarter 2007 Results
11. Callisto Reports on Second-Quarter 2007 Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  Rebiotix Inc. announced this morning that results of ... RBX2660 (microbiota suspension) will be presented in two posters and ... Philadelphia from October 8-12. ... session on Thursday, October 9, 2014: Poster: RBX2660 ... Interim Analysis of the PUNCH-CD Phase 2 Safety Study ...
(Date:9/17/2014)... 17, 2014  Bayer HealthCare will present data on ... th Annual Meeting, which takes place September 18-20 ... which will be shared through poster presentations, showcase Bayer,s ... Data will be presented in a scientific forum. ... in hemophilia A patients, Bayer is maintaining its commitment ...
(Date:9/17/2014)... September 17, 2014 According to ... Component (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU), by ... Wellness), and by Geography - Global Forecast to 2020", ... market is expected to reach $56.50 Billion by 2020, ... 2020. Browse 235 market data Tables and ...
Breaking Medicine Technology:PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4
... (Nasdaq: ENDP ) today announced that it will present ... 2011 at 3:45 p.m. ET.  Dr. Ivan Gergel executive vice president ... programs. The presentation will be webcast live and can ... investors section.   About Endo ...
... nation,s leading retail pharmacy, brings its "To Your Health" ... Texas. The program will provide free preventive health screenings ... through November as a way to help citizens determine ... a path to better health. (Logo: ...
Cached Medicine Technology:CVS/pharmacy Debuts the 'To Your Health' Program in Dallas and Fort Worth Texas, Bringing More Than 80 Free Health Screening Events to the Community 2CVS/pharmacy Debuts the 'To Your Health' Program in Dallas and Fort Worth Texas, Bringing More Than 80 Free Health Screening Events to the Community 3
(Date:9/18/2014)... Angeles, CA (September 18, 2014) Cardiovascular disease is ... cholesterol plays a major role in accelerating its ... a treatment to decrease cholesterol-carrying lipoproteins such as ... harmful. A new study, out today in the ... finds that rosuvastatin may be more effective among ...
(Date:9/18/2014)... 2014 On August 23, the ... with the Distinguished Service Award for his contributions to ... 2014 National Basketball Retired Players Association (NBRPA) Legends World ... the Chicago Bulls in 1977, Glenn would go on ... Knicks, the Atlanta Hawks, and the Milwaukee Bucks throughout ...
(Date:9/18/2014)... September 18, 2014 One Week Kitchens will ... the Bloomsburg Fair beginning this Saturday. Their display will be ... great example of the products and design services that are ... various countertops for fair-goers to see. This display won ‘Most ... earlier this year and really is something to see. ...
(Date:9/18/2014)... September 18, 2014 Demand for competency-based ... seek more efficient routes to job placement and employers ... not have come at a better time as the ... supply. , Working in collaboration with employers, career educators ... approach to CBE implementation and direct assessment ...
(Date:9/18/2014)... 2014 SpineFrontier is expanding its ... partners in Less Exposure Surgery Technology by hiring ... an extensive education curriculum and trained sales representatives ... in Organizational Leadership, and has educated and trained ... Bringing her to the team is a big ...
Breaking Medicine News(10 mins):Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 2Health News:The HearStrong Foundation Recognizes Mike “Stinger” Glenn with the Distinguished Service Award at the 2014 Legends World Sports Conference 3Health News:One Week Kitchens Taking Display to Bloomsburg Fair 2Health News:Wonderlic Unites Employers, Career Educators and Competency-Based Education Experts to Help Narrow Skills Gap 2Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2
... has come out with a finding published in the journal ... substance like marijuana, alcohol, and cigarettes in solitude, tend to ... to have a harder time quitting, as opposed to those ... ,The results stem from a study spreading over ...
... genome is remarkably similar to that of humans' and may ... //University of Central Florida professor Cristina Calestani and several colleagues ... November issue of Science. ,Sea urchins are ... sea urchin has been used for many years as a ...
... reports success of rapid 3-D cell-growth technique that produces ... lab, it looks, contracts //and responds almost like natural ... goal of creating replacement parts for damaged human hearts, ... a spoonful of loose heart cells. ,This ...
... will do the rounds of rural areas as part of ... marginalized populations. // ,The government has released initial ... to set up mobile medical units in rural areas. ... been given under the National Rural Health Mission (NRHM) scheme ...
... Brain scans may help doctors predict schizophrenia, a mental disorder ... a new study. // ,Researchers at the University of ... a high risk of developing schizophrenia because two or more ... online edition of BBC News said. ,The researchers ...
... scheme 'Assistance for capacity Building', Ministry of Health ... maximum //of Rs. 1.50 crores or actual, whichever ... facilities of State Hospitals of towns/cities located on ... Department of Road Transport and Highways and Ministry ...
Cached Medicine News:Health News:Sea Urchin Genome Similar To Man And May Cure Diseases 2Health News:A New Rapid 3-D Cell-Growth Technique For Growing Heart Muscle 2Health News:A New Rapid 3-D Cell-Growth Technique For Growing Heart Muscle 3
1% tryptone, 0.5% yeast extract, 1.0% Sodium Chloride. 1.5% agararose...
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
Inoculum Broth with Calcium Chloride and Phytone....
Medicine Products: